Machine learning algorithms in constructing prediction models for assisted reproductive technology (ART) related live birth outcomes.

Journal: Scientific reports
PMID:

Abstract

Currently applicable models for predicting live birth outcomes in patients who received assisted reproductive technology (ART) have methodological or study design limitations that greatly obstruct their dissemination and application. Models suitable for Chinese couples have not yet been identified. We conducted a retrospective study by using a database includes a total of 11,938 couples who underwent in vitro fertilization (IVF) treatment between January 2015 and December 2022 in a medical institution of southwest China Yunnan province. Multiple candidate predictors were screened out by using the importance scores. Four machine learning (ML) algorithms including random forest, extreme gradient boosting, light gradient boosting machine and binary logistic regression were used to construct prediction models. An initial assessment of the predictive performance was conducted and validated by using cross-validation and bootstrap methods. A total of seven predictors were identified, namely maternal age, duration of infertility, basal follicle-stimulating hormone (FSH), progressive sperm motility, progesterone (P) on HCG day, estradiol (E2) on HCG day, and luteinizing hormone (LH) on HCG day. Of the four predictive models, the random forest model and the logistic regression model were considered to have the optimal performance, with the areas under the receiver operating characteristic curve (AUROC) curves of 0.671 (95% CI 0.630-0.713) and 0.674 (95% CI 0.627-0.720). The Brier scores were 0.183 (95% CI 0.170-0.196) and 0.183 (95% CI 0.170-0.196), respectively. Considering the simplicity of model fitting, we recommend the logistic regression model as the best predictive model for live birth. Furthermore, maternal age, P on HCG day and E2 on HCG day were deemed to have the highest contribution to model prediction.

Authors

  • Junwei Peng
    Reproductive Medicine Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Xiaoyujie Geng
    Reproductive Medicine Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Yiyue Zhao
    Reproductive Medicine Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Zhijin Hou
    Reproductive Medicine Department, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Xin Tian
    Cancer Hospital Chinese Academy of Medical Sciences (Shenzhen Hospital), Shenzhen, 518000, China. Electronic address: 947952187@qq.com.
  • Xinyi Liu
    Department of Pharmacy, Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Yuanyuan Xiao
    Division of Epidemiology and Health Statistics, School of Public Health, Kunming Medical University, Kunming, China. 33225647@qq.com.
  • Yang Liu
    Department of Computer Science, Hong Kong Baptist University, Hong Kong, China.